IL61902A - Kijanimicin,process for its preparation and pharmaceutical compositions containing it - Google Patents

Kijanimicin,process for its preparation and pharmaceutical compositions containing it

Info

Publication number
IL61902A
IL61902A IL61902A IL6190281A IL61902A IL 61902 A IL61902 A IL 61902A IL 61902 A IL61902 A IL 61902A IL 6190281 A IL6190281 A IL 6190281A IL 61902 A IL61902 A IL 61902A
Authority
IL
Israel
Prior art keywords
kijanimicin
preparation
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
IL61902A
Other languages
English (en)
Other versions
IL61902A0 (en
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL61902A0 publication Critical patent/IL61902A0/xx
Publication of IL61902A publication Critical patent/IL61902A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/03Actinomadura
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL61902A 1980-01-17 1981-01-13 Kijanimicin,process for its preparation and pharmaceutical compositions containing it IL61902A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11276080A 1980-01-17 1980-01-17
US06/195,048 US4375542A (en) 1980-01-17 1980-10-08 Kijanimicin antibiotics and derivatives thereof

Publications (2)

Publication Number Publication Date
IL61902A0 IL61902A0 (en) 1981-02-27
IL61902A true IL61902A (en) 1984-10-31

Family

ID=26810312

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61902A IL61902A (en) 1980-01-17 1981-01-13 Kijanimicin,process for its preparation and pharmaceutical compositions containing it

Country Status (20)

Country Link
US (1) US4375542A (es)
EP (1) EP0033840B1 (es)
JP (1) JPS56118078A (es)
KR (1) KR840000751B1 (es)
AR (1) AR226337A1 (es)
AT (1) ATE8798T1 (es)
AU (1) AU543520B2 (es)
CA (1) CA1177426A (es)
DE (1) DE3164568D1 (es)
DK (1) DK149823C (es)
ES (1) ES498452A0 (es)
FI (1) FI69099C (es)
HU (1) HU181799B (es)
IE (1) IE50810B1 (es)
IL (1) IL61902A (es)
NO (1) NO155732C (es)
NZ (1) NZ196006A (es)
PH (1) PH17057A (es)
PT (1) PT72348B (es)
ZA (1) ZA81217B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983525A (en) * 1987-07-02 1991-01-08 American Cyanamid Company Plasmids derived from actinomadura species
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
CA2342325A1 (en) 1998-08-31 2000-03-09 Kyowa Hakko Kogyo Co., Ltd. An agent for inducing apoptosis
DE60136067D1 (de) * 2000-04-26 2008-11-20 Meiji Seika Kaisha Gemische zur behandlung oder prävention von malaria und verfahren zur behandlung von malaria
AU2002330374A1 (en) * 2001-11-22 2003-06-10 Kazuo Shinya Novel tetronic acid dervative
US8754054B2 (en) 2010-07-09 2014-06-17 Albany Molecular Research, Inc. Antibacterial compounds, methods of making them, and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364113A (en) * 1962-04-23 1968-01-16 Westminster Lab Ltd Senna preparations and methods of making and using them
FR1530409A (fr) * 1963-08-28 1968-06-28 Nouveaux dérivés de l'asiaticoside et leur procédé de préparation
US3723410A (en) * 1970-12-01 1973-03-27 Amazon Natural Drug Co Method of producing stevioside
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent

Also Published As

Publication number Publication date
ES8200922A1 (es) 1981-11-16
HU181799B (en) 1983-11-28
KR830005360A (ko) 1983-08-13
FI810078L (fi) 1981-07-18
ES498452A0 (es) 1981-11-16
DK149823B (da) 1986-10-06
NO155732C (no) 1987-05-20
JPH0327559B2 (es) 1991-04-16
KR840000751B1 (ko) 1984-05-31
AU6619181A (en) 1981-07-23
PH17057A (en) 1984-05-17
DE3164568D1 (en) 1984-09-06
IE50810B1 (en) 1986-07-23
DK149823C (da) 1987-03-16
FI69099B (fi) 1985-08-30
AR226337A1 (es) 1982-06-30
EP0033840A3 (en) 1981-12-02
AU543520B2 (en) 1985-04-26
CA1177426A (en) 1984-11-06
NO155732B (no) 1987-02-09
FI69099C (fi) 1985-12-10
DK12581A (da) 1981-07-18
IL61902A0 (en) 1981-02-27
EP0033840A2 (en) 1981-08-19
NZ196006A (en) 1983-09-02
ATE8798T1 (de) 1984-08-15
PT72348B (en) 1981-12-18
IE810054L (en) 1981-07-17
ZA81217B (en) 1982-01-27
US4375542A (en) 1983-03-01
PT72348A (en) 1981-02-01
NO810114L (no) 1981-07-20
EP0033840B1 (en) 1984-08-01
JPS56118078A (en) 1981-09-16

Similar Documents

Publication Publication Date Title
DE3263633D1 (en) Imidazodiazepines, process for their preparation and pharmaceutical compositions containing them
IL62082A0 (en) -lactam derivatives,process for the preparation thereof and pharmaceutical compositions containing them
DE3166619D1 (en) 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, process for their preparation and pharmaceutical compositions containing them
IL63968A0 (en) Aminoalkylfuran derivative,its preparation and pharmaceutical compositions containing it
DE3161838D1 (en) Solid pharmaceutical compositions containing nifedipine, and process for their preparation
ZA818371B (en) Nortropanols,their preparation and pharmaceutical compositions containing these
IL63801A (en) 2-amino-3-carbethoxyamino-6-(p-fluorobenzylamino)-pyridine-maleate,its production and pharmaceutical compositions containing it
DE3160805D1 (en) Antiallergic imidodisulfamides, pharmaceutical compositions containing them and process for their preparation
IL62641A0 (en) Xanthines,processes for their preparation and pharmaceutical compositions containing same
DE3176154D1 (en) Cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds
DE3161238D1 (en) 20-deoxyrosaramicin derivatives, process for their preparation and pharmaceutical compositions containing them
ZA818867B (en) Pyrazoloindazole derivatives,process for preparing the same,and pharmaceutical compositions containing the same
IL69735A (en) 1-phenyl-1-aminoalkyl-cyclobutane derivatives,process for their preparation and pharmaceutical compositions containing them
DE2961285D1 (en) Frenolicin b, process for preparation thereof and pharmaceutical compositions containing it
IL61902A (en) Kijanimicin,process for its preparation and pharmaceutical compositions containing it
IL64123A (en) Biphenylyloxypropoxypyrimidine derivatives,process for their preparation and pharmaceutical compositions containing them
ZA818609B (en) Pyrimidones,process for their preparation and pharmaceutical compositions containing them
IL62747A0 (en) 2-guanidinothiazole derivatives,process for the preparation thereof and pharmaceutical compositions comprising the same
DE3160797D1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
IL65368A0 (en) Mercapto acyl-carnitines,process for their preparation and pharmaceutical compositions containing same
DE3167471D1 (en) Benzoquinolizines, processes for their preparation and pharmaceutical compositions
DE3160290D1 (en) Hypoglycemic guanylamidines, processes for their preparation, and pharmaceutical compositions containing them
DE3372968D1 (en) Heterocyclyl-thio compounds, process for their preparation, pharmaceutical compositions containing them and their use
DE3174158D1 (en) New peptide, process for preparation thereof and pharmaceutical composition containing it
ZA812614B (en) Bis-hydroxybenzyl derivatives, processes for their preparation and pharmaceutical composition containing same